Session Chair Profile

Ph.D., CEO, Sema4; Dean for Precision Medicine and the Jean C. and James W. Crystal Professor of Genomics at the Icahn School of Medicine at Mount Sinai

Eric Schadt was previously Founding Director of the Icahn Institute for Genomics and Multiscale Biology, and Professor and Chair of the Department of Genetics and Genomic Sciences. Dr. Schadt is an expert on constructing predictive models of disease that link molecular biology to physiology to enable clinical medicine. Over the past 20 years, he has built groups and companies (Merck, Rosetta, Sage Bionetworks, Pacific Biosciences, Icahn Institute, and now Sema4) to elucidate the complexity of human diseases. He has published more than 350 peer-reviewed papers in leading scientific journals, and contributed to a number of discoveries relating to the genetic basis of common human diseases such as diabetes, obesity, and Alzheimer’s disease.

Session Abstract – PMWC 2018 Silicon Valley

Session Synopsis: Interpreting human DNA and predicting the molecular effects of genetic variation will aid in the understanding of human disease and is expected to increasingly provide personalized insights on health risks and recommended disease treatment. The rapid commercialization of AI/machine learning and big data is well positioned to over time change disease diagnosis and management.


Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To recieve the lastest news and updates from the field, subscribe to the newsletter here.

You have Successfully Subscribed!